[The progress of novel drug delivery systems].

药学学报 Pub Date : 2017-02-01
Hui-le Gao, Xin-guo Jiang
{"title":"[The progress of novel drug delivery systems].","authors":"Hui-le Gao,&nbsp;Xin-guo Jiang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The development of pharmaceuticals has been providing many kinds of novel drug delivery\nsystems, which are important for improving therapeutic effect and one of the most important fields in pharmaceutics.\nAccording to their application, we can generally divide the novel drug delivery systems into three categories:\nquickly performed drug delivery system, long-term drug delivery system and high effective drug delivery system.\nSome diseases, such as asthma, angina pectoris and migraine, require therapeutics urgently, and the drugs have to\nbe absorbed in several minutes. Therefore, quickly performed drug delivery systems are developed, such as oral\ndisintegrating tablets and nasal spray. For normal tablets and capsules, especially the drugs with short blood\nhalf life, the drug concentration in blood shows obvious peak-valley phenomenon, which reduces the therapeutic\neffect and requires multiple administration. To solve this problem, sustained drug release system was developed,\nwhich could release the drugs slowly and sustainably even in zero-order kinetics. The pulse drug delivery system\nwas developed that can delayed and pulsed release drug for one or several times. This system is especially\nuseful in the management of asthma and heart disease, which are often found in midnight or early morning when\npatients are in bed. Transdermal drug delivery system could release drugs sustainably and deliver the drugs\nthrough skin to blood circulation, providing long term activity. The water-insoluble drugs are difficult for\npharmaceutical development, thus many methods were developed to improve the solubility and bioavailability of\ndrugs. Although biopharmaceuticals are important for disease treatment, the application shadows by the poor\nstability and low bioavailability. Thus the biopharmaceutical delivery system was developed, which mainly\nfocused on structure modification and encapsulation by carriers. Considering therapeutic effect requires\ninteraction between drugs and their targets, it is important to deliver drugs to their targets. Therefore, targeting\ndelivery systems were developed, which mainly based on the nanoparticles. Furthermore, on-demand release\ndrug delivery systems are also developed with the property of environment-triggered drug release. In conclusion,\nthe novel drug delivery systems were reviewed in this study.</p>","PeriodicalId":35924,"journal":{"name":"药学学报","volume":"52 2","pages":"181-8"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"药学学报","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The development of pharmaceuticals has been providing many kinds of novel drug delivery systems, which are important for improving therapeutic effect and one of the most important fields in pharmaceutics. According to their application, we can generally divide the novel drug delivery systems into three categories: quickly performed drug delivery system, long-term drug delivery system and high effective drug delivery system. Some diseases, such as asthma, angina pectoris and migraine, require therapeutics urgently, and the drugs have to be absorbed in several minutes. Therefore, quickly performed drug delivery systems are developed, such as oral disintegrating tablets and nasal spray. For normal tablets and capsules, especially the drugs with short blood half life, the drug concentration in blood shows obvious peak-valley phenomenon, which reduces the therapeutic effect and requires multiple administration. To solve this problem, sustained drug release system was developed, which could release the drugs slowly and sustainably even in zero-order kinetics. The pulse drug delivery system was developed that can delayed and pulsed release drug for one or several times. This system is especially useful in the management of asthma and heart disease, which are often found in midnight or early morning when patients are in bed. Transdermal drug delivery system could release drugs sustainably and deliver the drugs through skin to blood circulation, providing long term activity. The water-insoluble drugs are difficult for pharmaceutical development, thus many methods were developed to improve the solubility and bioavailability of drugs. Although biopharmaceuticals are important for disease treatment, the application shadows by the poor stability and low bioavailability. Thus the biopharmaceutical delivery system was developed, which mainly focused on structure modification and encapsulation by carriers. Considering therapeutic effect requires interaction between drugs and their targets, it is important to deliver drugs to their targets. Therefore, targeting delivery systems were developed, which mainly based on the nanoparticles. Furthermore, on-demand release drug delivery systems are also developed with the property of environment-triggered drug release. In conclusion, the novel drug delivery systems were reviewed in this study.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[新型给药系统的进展]。
药物的发展提供了多种新型给药系统,对提高药物治疗效果具有重要意义,是药剂学的重要领域之一。根据其应用,我们一般可以将新型给药系统分为三类:快速给药系统、长效给药系统和高效给药系统。有些疾病,如哮喘、心绞痛和偏头痛,迫切需要治疗,药物必须在几分钟内被吸收。因此,开发了快速给药系统,如口腔崩解片和鼻喷雾剂。对于普通片剂、胶囊,特别是血半衰期较短的药物,其血药浓度呈明显的峰谷现象,降低了疗效,需要多次给药。为了解决这一问题,开发了药物缓释系统,该系统可以在零级动力学下缓慢持续释放药物。研制了一种脉冲给药系统,可将药物延迟一次或多次脉冲释放。这个系统在哮喘和心脏病的治疗中特别有用,这两种疾病通常在午夜或清晨患者卧床时出现。经皮给药系统可以持续释放药物,并通过皮肤进入血液循环,具有长期活性。水不溶性药物是药物开发的难点,因此开发了许多方法来提高药物的溶解度和生物利用度。生物制药在疾病治疗中发挥着重要作用,但稳定性差、生物利用度低等问题制约了生物制药的应用。因此,生物药物给药系统的发展主要集中在结构修饰和载体的封装上。考虑到治疗效果需要药物与靶点的相互作用,将药物送到靶点是很重要的。因此,主要基于纳米颗粒的靶向递送系统得到了发展。此外,还开发了具有环境触发药物释放特性的按需释放药物递送系统。最后,本文对新型给药系统进行了综述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
药学学报
药学学报 Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.20
自引率
0.00%
发文量
0
期刊介绍: Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent advances. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics. APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953. The journal is co-published by Elsevier B.V., in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.
期刊最新文献
[Protection effects of schizandrin B against liver injury induced by clozapine in mice]. [Effect of apigenin on dendritic cells maturation and function in murine splenocytes]. [Advances and challenges in preclinical evaluation of therapeutic drugs for treating ischemic stroke]. [Advances in the study of the rat model of aging induced by D-galactose] [Current status of ion channels as drug targets for diabetic neuropathic pain].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1